Advertisement

Topics

Medicare decides against tighter management of HIV drugs

08:00 EDT 17 May 2019 | BioPharmaDive

A finalized regulation codifies step therapy and prior authorization practices in five of the Medicare Part D "protected" drug classes, but spares HIV.

Original Article: Medicare decides against tighter management of HIV drugs

NEXT ARTICLE

More From BioPortfolio on "Medicare decides against tighter management of HIV drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...